A New Target to Boost Cancer Immunotherapy: LAG-3
Emerging research suggests that cancer therapies such as checkpoint inhibitors could be advanced by targeting a new protein. The protein, known as lymphocyte activation gene-3 or LAG-3, may prove particularly useful in improving patient responses to existing cancer treatments. Killing Cancer with …
How Cancer Immunotherapy Checkpoint Inhibitors Work
Skin cancers, lung cancers, lymphomas—though these cancers affect different parts of the body, they can all be treated with one of the latest therapies medicine has to offer: checkpoint inhibitors. This family of anticancer drugs can treat over 25 different types of …
Cancer Therapy And The Intestinal Microbiome
A study published in Nature suggests a variation in responses to a cancer immunotherapy called checkpoint inhibitors may be due—at least in part—to a patient’s intestinal microbiome. Turning to the Intestines There are other similar reports that paint a connection between the …
A New Immunotherapy For Cancer: PD-L2
PD-1 checkpoint proteins on T cells (blue) can bind to two different receptors: PD-L1 and PD-L2.ACCESS HEALTH INTERNATIONAL There are many ways to climb a mountain. This saying especially rings true in cancer research, where scientists are probing several avenues to combat …
Tackling Hard-to-Treat Tumors
Solid tumors are notoriously difficult to suppress. They survive and thrive in the body despite best efforts to control them—resisting even the latest immunotherapies such as PD-1 and PD-L1 targeting checkpoint inhibitors. One of the ways researchers are trying to address this …
Another Approach To Checkpoint Inhibitors: Targeting Receptors
In a previous story, I discussed a cancer advance called PD-1 checkpoint inhibitors which has proven effective yet imperfect against several tumors. The technology blocks a molecule widely found on white blood T cells. Yet, there is another way to achieve this …
Driving Screening for Cervical Cancer and Other NCDs in Bahriach
On June 16th, ACCESS Health India, in collaboration with the State Health Agency for Comprehensive Health and Integrated Services (SAHIS) and Pathkind Labs, organized an NCD Screening Camp in the district of Bahriach, Uttar Pradesh, India. Conducted at CHC Kaiserganj, the camp …
Enhancing the Standards of Cancer Care in Uttar Pradesh
As a part of our ongoing work on Cancer care in Uttar Pradesh, ACCESS Health organized a discussion with stakeholders from the private and public sectors to enhance the standards of cancer care in the state. The objective of the discussion was …
Recent Comments